| CYSB1000216 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2011-02-25 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2013-11-20 | view |
| CYHB1902858 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2019-05-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2019-08-30 | view |
| CYHB1803949 | 索磷布韦片 | Sofosbuvir | Tablet | Chemical Drugs | Supplementary Application | 2018-07-30 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-03-19 | view |
| CYHB1204218 | 复方甘草酸苷片 | Glycyrrhizin;Glycine;DL-Methionine | Tablet | Chemical Drugs | Supplementary Application | 2012-07-06 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2013-04-23 | view |
| CYHS1400991 | 恩替卡韦片 | entecavir | Tablet | Chemical Drugs(6) | Generic Drug | 2015-02-03 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2017-02-13 | view |
| CXHB0801684 | 对甲苯磺酸二硫酸腺苷蛋氨酸 | Ademetionine disulfate tosylate | Active ingredient | Chemical Drugs | Supplementary Application | 2009-04-03 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2009-12-07 | view |
| CYSB1600190 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2017-05-11 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2018-06-28 | view |
| CYHS1001028 | 丁二磺酸腺苷蛋氨酸 | ademetionine | Active ingredient | Chemical Drugs(6) | Generic Drug | 2011-09-14 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2017-01-23 | view |
| CYHB2004474 | 索磷布韦片 | Sofosbuvir | Tablet | Chemical Drugs | Supplementary Application | 2020-06-13 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-09-16 | view |
| CYSB1800231 | 重组人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products | Supplementary Application | 2018-10-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-11-03 | view |
| CXHL1401837 | KW-136胶囊 | coblopasvir hydrochloride | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-01-04 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2016-05-05 | view |
| CXHB0801682 | 注射用对甲苯磺酸二硫酸腺苷蛋氨酸 | Ademetionine disulfate tosylate | Lyophilized | Chemical Drugs | Supplementary Application | 2009-03-02 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2009-07-31 | view |
| CYHS1400846 | 门冬氨酸鸟氨酸注射液 | Ornithine Aspartate | Injection | Chemical Drugs(6) | Generic Drug | 2016-04-01 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2017-07-21 | view |
| CYSB1100346 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2011-11-01 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2013-01-10 | view |
| CXSL1400125 | 注射用重组人白细胞介素15 | | Lyophilized | Biological Products(1) | New Drug Application | 2015-01-19 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2016-11-09 | view |
| CYHB0812579 | 注射用胸腺五肽 | thymopentin | Lyophilized | Chemical Drugs | Supplementary Application | 2009-03-25 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Completed-Pending Issued | 2009-06-01 | view |
| CXHL1600290 | KW-136片 | coblopasvir hydrochloride | Tablet | Chemical Drugs(1) | New Drug Application | 2017-04-13 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2017-11-30 | view |
| CYHS1001029 | 注射用丁二磺酸腺苷蛋氨酸 | ademetionine | Lyophilized | Chemical Drugs(6) | Generic Drug | 2011-09-14 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2017-01-23 | view |
| CYHB1902857 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2019-05-30 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2019-08-30 | view |
| CYSB1800230 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2018-10-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-10-27 | view |
